title: Antitumor activity of extracts and compounds from the skin of the toad Bufo bufo gargarizans Cantor.
abstract: The skin of the toad Bufo bufo gargarizans Cantor is known to be rich in bufadienolides, peptides and alkaloids. It has been found to be a source of some extracts and biologically active compounds with antitumor activity. Cinobufacini (Huachansu), a Chinese medicine prepared from the dried toad skin, has been widely used in clinical therapy for various cancers in China. Bufadienolides, such as bufalin, cinobufagin, resibufogenin, and telocinobufagin, are the major active compounds derived from the toad skin. They are the maker biologically active compounds of cinobufagin while the antitumor activity of cinobufagin may be due to this kind of components. Experimental research has suggested that cinobufacini and its active compounds (e.g. bufalin and cinobufagin) exhibit significant antitumor activity, including inhibition of cell proliferation, induction of cell differentiation, induction of apoptosis, disruption of the cell cycle, inhibition of cancer angiogenesis, reversal of multi-drug resistance, and regulation of the immune response. Clinical data have indicated that cinobufacini may have effective anticancer activity with low toxicity and few side effects. Data to date suggest it may also enhance quality of life for patients with cancer. Thus, this review briefly summarizes recent studies on the anticancer activity of cinobufacini and some of its active compounds from the skin of the toad Bufo bufo gargarizans Cantor. This might provide additional evidence for further study of the extracts and active compounds from the toad skin in cancer treatment.
authors.affiliation: Hepato-Biliary-Pancreatic Surgery Division, Department of Surgery, Graduate School of Medicine, The University of Tokyo, Bunkyo-ku, Tokyo 113-8655, Japan.
authors.forename: Fanghua
authors.initials: F
authors.lastname: Qi
authors.forename: Anyuan
authors.initials: A
authors.lastname: Li
authors.forename: Yoshinori
authors.initials: Y
authors.lastname: Inagaki
authors.forename: Norihiro
authors.initials: N
authors.lastname: Kokudo
authors.forename: Sumihito
authors.initials: S
authors.lastname: Tamura
authors.forename: Munehiro
authors.initials: M
authors.lastname: Nakata
authors.forename: Wei
authors.initials: W
authors.lastname: Tang
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000494:pharmacology*; D002023:Bufo bufo / Q000378:metabolism*; D045744:Cell Line, Tumor; D006801:Humans; D008516:Medicine, Chinese Traditional; D015394:Molecular Structure; D012867:Skin / Q000737:chemistry*
chemical_list: D000970:Antineoplastic Agents